My ePortfolio Register   

Anti-angiogenic therapy as treatment for breast cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 13.08.10
Views: 6604

Dr Francesco Bertolini - European Institute of Oncology, Milan, Italy

Dr Bertolini speaks to about his research into anti-angiogenic therapy as treatment for breast cancer. Anti-angiogenic therapy has been successful increasing progression free survival, but has not yet achieved an increase in overall survival. Dr Bertolini's team is now looking to see how the combination of chemotherapy and anti-angiogenic therapy can be improved and are also working with surrogate biomarkers to identify which patients are suited to particular treatments.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence